Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review

Sellas Life Sciences Group Inc SLS:

• SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATION

• SELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIAL

• SELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTS